[go: up one dir, main page]

Uddin et al., 2016 - Google Patents

Pharmacopoeial standards and specifications for pharmaceutical aerosols: In-process and finished products quality control tests

Uddin et al., 2016

View PDF
Document ID
6810727701572011909
Author
Uddin M
Hossain M
Mamun A
Zaman S
Asaduzzaman M
Rashid M
et al.
Publication year
Publication venue
Adv Res

External Links

Snippet

Pharmaceutical aerosol is a pressurized system that depends on the power of a compressed or liquefied gas to expel the contents from the container. Therapeutic performance of pharmaceutical aerosols is affected by various factors such as actuator tube design, orifice …
Continue reading at pdfs.semanticscholar.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carier particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/22—Devices for withdrawing samples in the gaseous state

Similar Documents

Publication Publication Date Title
US7453556B2 (en) Process for determining the particle size distribution of an aerosol and apparatus for carrying out such a process
US7414720B2 (en) Measuring particle size distribution in pharmaceutical aerosols
Lu et al. International guidelines for bioequivalence of locally acting orally inhaled drug products: similarities and differences
Drug Guidance for industry
Uddin et al. Pharmacopoeial standards and specifications for pharmaceutical aerosols: In-process and finished products quality control tests
Abdo et al. Quality control and testing evaluation of pharmaceutical aerosols
Shur et al. Effect of device design and formulation on the in vitro comparability for multi-unit dose dry powder inhalers
Baxter et al. Spray pattern and plume geometry testing and methodology: an IPAC-RS working group overview
Scherer et al. A technical feasibility study of dornase alfa delivery with eFlow® vibrating membrane nebulizers: aerosol characteristics and physicochemical stability
Sawatdee et al. Formulation development and in-vitro evaluation of montelukast sodium pressurized metered dose inhaler
Nadarassan et al. Aerodynamic characteristics of a dry powder inhaler at low inhalation flows using a mixing inlet with an Andersen Cascade Impactor
Doub et al. Measurement of drug in small particles from aqueous nasal sprays by Andersen Cascade Impactor
Uddin QUALITY CONTROL TESTS FOR PHARMA-CEUTICAL AEROSOLS
Moraga-Espinoza et al. Mass Median Plume Angle: A novel approach to characterize plume geometry in solution based pMDIs
Bezuglaya et al. Study of pressurised metered dose inhalers for the purpose of standardization of quality attributes characterizing uniformity of dosing
ADAMS et al. Regulatory aspects of modifications to innovator bronchodilator metered dose inhalers and development of generic substitutes
Lewis et al. Defining the ‘dose’for dry powder inhalers: the challenge of correlating In-vitro dose delivery results with clinical efficacy
US20050238588A1 (en) Process for determining the particle size distribution of an aerosol and apparatus for carrying out such a process
Zeng et al. Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulations
Gondhale-Karpe et al. Analytical Tools for the Characterization of Nasal Spray Drug Products
Mitchell Aerodynamic Particle Size Testing
US20090121722A1 (en) Method for Assessing the Suitability of Metered Dose Inhaler Actuators
Jaiswal et al. A comparative study of regulations of nasal products in the US and EU
Nagel et al. Size analysis of a pressurized metered dose inhaler-delivered solution formulation by an Aerosizer®-LD time-of-flight aerosol particle size spectrometer
Hickey Pharmacopeial and Regulatory Guidances on Product Quality and Performance